T1	p 47 69	the premature monkey :
T2	p 196 276	premature monkey ( Macaca nemestrina ) model of hyaline membrane disease ( HMD )
T3	i 81 106	antenatal dexamethasone .
T4	i 137 171	antenatal glucocorticoid treatment
T5	i 215 234	Macaca nemestrina )
T6	i 286 327	dams received dexamethasone ( 2 mg/dose )
T7	i 438 444	saline
T8	i 480 484	dams
T9	i 1512 1525	dexamethasone
T10	i 1623 1646	Antenatal dexamethasone
T11	o 509 538	incidence and severity of HMD
T12	o 615 626	Improvement
T13	o 707 734	volume-pressure behavior of
T14	o 747 799	lungs included greater distensibility in the infants
T15	o 805 831	dexamethasone-treated dams
T16	o 915 934	deflation stability
T17	o 940 1023	treatment . Accelerated production of surface active material ( SAM ) phospholipids
T18	o 1097 1122	total lung phospholipid (
T19	o 1194 1228	alveolar lavage fluid phospholipid
T20	o 1303 1368	and alveolar lavage fluid disaturated phosphatidylcholine ( DPC )
T21	o 1443 1489	Incorporation of 14C-palmitate into lung lipid
T22	o 1688 1710	incidence and severity
T23	o 1823 1833	maturation